Tech Center 1600 • Art Units: 1619
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19342419 | FABRIC MATERIAL INFUSED OR IMPREGNATED WITH ONE OR MORE BENEFICIAL AGENTS AND METHOD OF MAKING THEREOF | Non-Final OA | BIO PROTECTANT TECHNOLOGIES, INC. |
| 17054441 | SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17636209 | Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders | Final Rejection | Arizona Board of Regents on behalf of Arizona State University |
| 17235771 | BIOLOGICALLY ACTIVE DRY POWDER COMPOSITIONS AND METHOD OF THEIR MANUFACTURE AND USE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18188899 | COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | Non-Final OA | Pearl Therapeutics, Inc. |
| 17306490 | METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE | Final Rejection | AltaThera Pharmaceuticals LLC |
| 18413456 | COMPOSITIONS AND METHODS FOR TREATING FLATWORMS | Non-Final OA | New Guinea Flatworm Spray, Inc. |
| 18001896 | TREATMENT OF ATRIAL DYSFUNCTION | Non-Final OA | MyoKardia, Inc. |
| 18513377 | DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF | Final Rejection | Insmed Incorporated |
| 18247637 | METHODS OF TREATING BONE INFECTIONS | Non-Final OA | MICROBION CORPORATION |
| 18269421 | PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | Non-Final OA | HK INNO.N CORPORATION |
| 18264815 | HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY | Non-Final OA | NIHON TRIM CO., LTD. |
| 17920984 | COMPOSITIONS AND METHODS FOR TREATING UPPER RESPIRATORY INFECTIONS | Non-Final OA | SaNOtize Research and Development Corp. |
| 18124977 | Window of Opportunity Skin Treatment Regimen and Composition for Preventing the Onset of or Treating Atopic Dermatitis | Non-Final OA | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND |
| 18174006 | Mollusc Barrier | Non-Final OA | Doff Portland Limited |
| 17874526 | SYNERGISTIC ACTIVITY OF NOVEL COMPOUNDS AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | Final Rejection | SterileCare Inc. |
| 18001582 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | Final Rejection | APHAIA IP AG |
| 17441915 | HYALURONIC ACID SKIN CARE COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF | Final Rejection | BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy